ZCT:TSXV, ZERO CANDIDA TECHNOLOGIES INC

ZCT stock overview

ZERO CANDIDA TECHNOLOGIES INC (ZCT:TSXV) closed at $0.110 on October 7, 2026, unchanged on the day. It is trading at its 52-week low of $0.110. Over the past year, it lost 60.7%. ZERO CANDIDA TECHNOLOGIES INC is part of the Miscellaneous sector.

Key figures

Price
$0.110
Day change
0.00%
Volume
5,000
Average volume
579
Market cap
2M+
52-week range
$0.110 – $0.280
50-day average
$0.144
200-day average
$0.167

Performance

5D 1M 3M 6M 1Y
0.00% -21.43% -26.67% -42.11% -60.71%

Price action over the past year

In 252 trading sessions since October 16, 2025, ZCT closed higher on 16 days (6%). Its best day was May 19, 2026 (+26.67%) and its worst was October 6, 2026 (-21.43%). The stock moved 10% or more in a single session 21 times. It opened at least 5% above the previous day's high 11 times.

Recent signals

About ZERO CANDIDA TECHNOLOGIES INC

Zero Candida is focused on commercial exploitation of a number of patents and patent applications with respect to an AI smart tampon-like device, designed to treat Candidiasis and transfer the medical information via Wi-Fi to the doctor. ZC technology is a combination of a therapy light source with a selected wavelength and intensity and a transparent gel-based drug delivery system to maintain the optimum Ph level in the vagina. The device when used overnight, demonstrated a 99.9999% Candidiasis elimination in the vagina within 3 nights. ZC developed a first prototype of its device in May of 2022 and immediately commenced its first laboratory tests as a "proof of concept". In September 2023 ZC completed its pre-clinical animal studies and subsequently developed a protype (1st series) and commenced its validation. ZC is currently in the process of developing the design of its device and continues pre-clinical animal studies.

Similar stocks

Find more stocks like ZCT with the Spikes, Gaps, Breakouts and Performance Tracker scanners.

Based on end-of-day data. For information only, not investment advice.